Healthcare finance, from a first clinic to a hospital group.
Twelve facilities covering the whole sector: professional loans for doctors, project finance for hospitals, equipment funding for imaging and OT, working capital against insurer receivables, and plant finance for pharma and medical device manufacturing.
Why healthcare is underwritten differently
Lenders treat healthcare as a preferred sector, and with reason: demand is inelastic, medical qualifications do not lose value in a downturn, and portfolio default rates on doctor and hospital lending run below general business lending. That shows up as better pricing, higher unsecured limits and dedicated healthcare desks at most large banks.
What lenders do watch closely is the payer mix. A facility earning from cash patients has immediate collections; one dependent on insurers, TPAs and government health schemes waits 60 to 120 days and absorbs claim deductions along the way. Two hospitals with identical revenue can have very different credit profiles because of it, and that gap is the reason working capital belongs in every healthcare funding plan rather than being an afterthought.
The most expensive error across this whole sector is instrument mismatch — taking unsecured professional money for a purpose that a secured facility would fund far more cheaply. A ₹2 Cr unsecured loan at 13% over seven years costs roughly ₹70 Lakh more in interest than the same amount secured at 10% over twelve. Speed is worth paying for sometimes; it is rarely worth paying that much.
Twelve facilities across healthcare and pharma
From a first clinic to a multi-city hospital group, and from a chemist shop to an API plant. Open the one that matches your requirement.
Doctor Loan
Collateral-free professional loans up to ₹5 Cr, priced on qualification and vintage.
View details →Hospital Construction & OT
Build or expand a nursing home or hospital — tranched, with a moratorium.
View details →Medical Equipment Loan
CT, MRI, cath lab, dialysis and OT equipment at 70–85% against the asset.
View details →Diagnostic Centre & Lab
Pathology labs, imaging centres and collection networks — equipment plus working capital.
View details →Pharmacy & Chemist Store
Inventory, fit-out and franchise funding for retail pharmacies.
View details →Pharma Manufacturing Loan
Formulation and API plants — clean rooms, utilities, validation and Schedule M upgrades.
View details →Pharma Distributor Loan
CC and OD limits for stockists and C&F agents, sized on stock and receivables.
View details →Medical Device Manufacturing
Disposables, implants and diagnostics — tooling, sterilisation, ISO 13485 and CDSCO.
View details →Healthcare Working Capital
Bridge the 60–120 day wait for insurers, TPAs and government health schemes.
View details →Pharma Machinery Loan
Tablet, injectable and packaging lines at 70–85%, new, imported or refurbished.
View details →Healthcare Infrastructure
Structured ₹10–100 Cr facilities for hospital groups and multi-city rollouts.
View details →Healthcare Startup Loan
First clinic or centre — routed through CGTMSE and scheme finance, not costly unsecured debt.
View details →Rate bands across the section
Indicative for mid-2026. Secured and scheme-backed structures sit far below commercial unsecured lending — which is the whole point of choosing carefully.
Sharpest — secured & project
Core — asset-backed
Widest — unsecured & startup
Three decisions that shape every healthcare file
Secured versus unsecured, decided on purpose
A qualification opens doors to fast unsecured money, and that convenience is heavily priced. If you are funding a building, a scanner or a production line, the asset can secure the loan and the saving over the tenure is very large. Reserve unsecured lines for genuinely short-term, unsecurable needs.
Capex and working capital sanctioned together
The recurring failure in this sector is a facility funded beautifully for equipment or construction and not at all for the receivable cycle that follows. New hospitals and labs hit that wall in their second or third quarter. Both components belong in one plan, sanctioned before commissioning.
Test scheme eligibility before commercial terms
CGTMSE, PMEGP, Stand-Up India, Mudra and CLCSS cover a great deal of healthcare and pharma activity, at bank pricing and often without collateral. Most first-time borrowers never check. Our government schemes desk runs that test before we look at commercial options.
Documents required
Incomplete files cause most multi-week delays. We assemble the full set upfront, in the order credit teams read it.
KYC & constitution
- PAN & Aadhaar of all promoters / partners / directors
- Certificate of incorporation, MOA-AOA or partnership deed
- Board resolution or partners' authority letter
- GST registration & trade licence
Professional & licences
- Degree and PG certificates; council registration
- Clinical establishment registration
- Drug licence, AERB, biomedical waste and pollution consents as applicable
- GMP / Schedule M status for manufacturing units
- Insurer, TPA and scheme empanelment letters
Financials
- 3 years ITR with computation of income
- Audited financials with schedules
- 12 months' bank statements and GST returns
- Receivable ageing by payer; stock statement where relevant
- Existing sanction letters and repayment track
How we run a healthcare file
Purpose and instrument test
We establish whether secured, unsecured or scheme-backed is right before approaching any lender — usually the largest saving in the whole exercise.
Capex plus working capital sizing
Equipment, construction and the receivable cycle modelled as one requirement, so nothing is stranded at commissioning.
Regulatory readiness
Council registration, clinical establishment, AERB, drug licence, GMP and empanelment checked and sequenced against disbursal conditions.
Placement across healthcare desks
Filed with the lenders running genuine healthcare policy for that sub-segment, run in parallel, tracked to disbursal.
Related facilities & deep-dive guides
Every facility below is placed through the same 80+ lender panel. The long-form guides carry the working numbers, worked examples and lender-by-lender detail.
Frequently Asked Questions
The questions our advisory desk is asked most often about Healthcare & Pharma Loans.
Broadly: scheme-backed and project-secured facilities price lowest, at roughly 9.25–12%; asset-backed equipment and working capital sit in the middle; and commercial unsecured lending to doctors, pharmacies and startups is the most expensive, reaching the mid-to-high teens.
The practical implication is to secure what can be secured. A building or a scanner can support its own loan far more cheaply than an unsecured line covering the same amount.
Yes. Professional loans for doctors run up to around ₹5 Crore unsecured, sized on qualification tier, practice vintage, declared income and credit score.
It is genuinely useful for short-term and unsecurable needs. For a building or major equipment, a secured project facility or equipment loan will cost you substantially less over the tenure.
Because insurers, TPAs and government schemes settle on 60 to 120 day cycles while salaries, consumables and pharmacy purchases are monthly. That gap is permanent and structural, not a temporary startup issue.
A cash credit limit sized on the receivable book bridges it, and charges interest only on what you draw. Arranging it before commissioning is far easier than after the squeeze arrives.
Yes, extensively. CGTMSE provides collateral-free cover on eligible MSME facilities, PMEGP and Mudra support smaller setups, Stand-Up India covers SC, ST and woman promoters, and CLCSS supports technology upgradation in manufacturing.
Most first-time healthcare borrowers never test eligibility and pay several percentage points more than they needed to. Our schemes desk checks this first as a matter of routine.
A clean unsecured doctor loan can disburse in three to seven working days. Equipment finance typically runs two to four weeks. Hospital project finance and pharma plant facilities take six to twelve weeks, and large structured group facilities two to four months.
Regulatory clearances rather than credit processing usually set the timeline — AERB licensing for imaging is the classic example, and it cannot be compressed.
Tell us what you need. We'll do the running around.
Share a few details and a CreditCares expert will call you back to map your eligibility and shortlist the right lenders — at no cost.